Generic placeholder image

Recent Patents on Nanotechnology

Editor-in-Chief

ISSN (Print): 1872-2105
ISSN (Online): 2212-4020

Research Article

A New Silver Nano-Formulation of Cassia auriculata Flower Extract and its Anti-Diabetic Effects

Author(s): Viswanathan Mariammal Berlin Grace*, Devarajan David Wilson, Divyadharshini M, Viswanathan S, Siddikuzzaman and ‪Rengaswamy Gopal

Volume 16, Issue 2, 2022

Published on: 29 March, 2021

Page: [160 - 169] Pages: 10

DOI: 10.2174/1872210515666210329160523

Price: $65

Abstract

Background: Treatment of diabetes mellitus (DM) using plant based drugs is advancing and getting much attention in recent years. Cassia auriculata L. is widely used in Indian folk medicine for the treatment of DM. Site-specific targeted plant drug delivery by metallic nanoparticles carriers is a new emerging procedure under research due to its enhanced bioavailability and reduced toxicity. This study was therefore aimed at biosynthesizing a new silver nanoparticle of Cassia auriculata L. flower extract and study its anti-diabetic efficiency in rats.

Methods: The silver nanoparticles were biosynthesized using AgNO3 solution and characterized by spectroscopy, SEM and EDAX analyses. The acute toxicity of this nano-preparation (up to 2000 mg/kg b. wt) was analyzed in rats and the anti-diabetic efficiency (for 50 mg/kg.b.wt and 200 mg/kg.b.wt) was studied in Streptozotocin induced diabetic rats. The diabetic parameters such as; blood glucose, serum protein, liver glycogen, serum lipid profile, serum levels of creatinine, urea, ALT, AST and ALP were analyzed. The histology of the liver, kidney and pancreas was evaluated after staining with Haematoxylin and Eosin.

Results: The increased blood glucose in Streptozotocin induced diabetic rats was found to be significantly reduced (p<0.01) in the treated group of rats. The characteristic damage and disorganization in the cells of Streptozotocin induced DM was found to be recovered in the treated group of rats. The alterations in the lipid profile, hyperglycaemia, reduced serum protein and liver glycogen, enhanced liver function and kidney function markers observed in the rats of DM control group were normalized in the treated group of rats.

Conclusion: The results of this study, proving an efficient anti-diabetic activity of the biosynthesized silver nanoparticles of Cassia auriculata L. flower extract, implies that this nano-preparation may be exploited as an alternative biopharmaceutical agent for treating DM.

Keywords: Cassia auriculata L., diabetes mellitus, silver nanoparticles, acute toxicity, anti-diabetic, Streptozotocin.

Graphical Abstract

[1]
Fröde TS, Medeiros YS. Animal models to test drugs with potential antidiabetic activity. J Ethnopharmacol 2008; 115(2): 173-83.
[http://dx.doi.org/10.1016/j.jep.2007.10.038] [PMID: 18068921]
[2]
Cooke DW, Plotnick L. Type 1 diabetes mellitus in pediatrics. Pediatr Rev 2008; 29(11): 374-84.
[http://dx.doi.org/10.1542/pir.29-11-374] [PMID: 18977856]
[3]
Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran Pathologic Basis of Disease, Professional Edition E-Book. Elsevier Health Sciences 2014.
[4]
Belfield A, Goldberg DM. Colorimetric determination of alkaline phosphatase activity. Enzyme 1971; 12(5): 561-8.
[http://dx.doi.org/10.1159/000459586] [PMID: 5169852]
[5]
Rupeshkumar M, Kavitha K, Haldar PK. Role of herbal plants in the diabetes mellitus therapy: an overview. Int J Appl Pharm 2014; 6(3): 1-3.
[6]
Semwal A, Kumar V, Bhatt SP, Ashok K. Medicinal plants with antiocular activities. Int J Med Res 2016; 1(2): 35-53.
[7]
Shanmugavel S, Karthikeyan V. Synthesis and characterization of layer by layer magnetic nanoparticles of methotrexate and melphalan. World J Pharm Pharm Sci 2013; 3(2): 1809-24.
[8]
Surendiran A, Sandhiya S, Pradhan SC, Adithan C. Novel applications of nanotechnology in medicine. Indian J Med Res 2009; 130(6): 689-701.
[PMID: 20090129]
[9]
Vimalanathan AB, Tyagi V, Rajesh A, Devanand P, Tyagi MG. Biosynthesis of silver nanoparticles using Chinese white ginseng plant root Panax ginseng. Asian J Biomed Pharm Sci 2013; 34: 1-6.
[10]
Parashar UK, Saxena PS, Srivastava A. Bioinspired synthesis of silver nanoparticles. Dig J Nanomater Biostruct 2009; 4(1): 159-66.
[11]
Chen Y, Wang C, Liu H, Qiu J, Bao X. Ag/SiO2: a novel catalyst with high activity and selectivity for hydrogenation of chloronitrobenzenes. Chem Commun (Camb) 2005; (42): 5298-300.
[http://dx.doi.org/10.1039/b509595f] [PMID: 16244734]
[12]
Setua P, Chakraborty A, Seth D, Bhatta MU, Satyam PV, Sarkar N. Synthesis, optical properties, and surface enhanced Raman scattering of silver nanoparticles in nonaqueous methanol reverse micelles. J Phys Chem C 2007; 111(10): 3901-7.
[http://dx.doi.org/10.1021/jp067475i]
[13]
Joshi SG. Medicinal plants Oxford and IBH publishing 2000.
[14]
Brahmachari HD, Augusti KT. Hypoglycaemic agents from Indian indigenous plants. J Pharm Pharmacol 1961; 13(1): 381-2.
[http://dx.doi.org/10.1111/j.2042-7158.1961.tb11839.x]
[15]
Pari L, Latha M. Effect of Cassia auriculata flowers on blood sugar levels, serum and tissue lipids in streptozotocin diabetic rats. Singapore Med J 2002; 43(12): 617-21.
[PMID: 12693765]
[16]
Velavan S, Arivoli P, Mahadevan K. Biological reduction of silver nanoparticles using Cassia auriculata flower extract and evaluation of their in vitro antioxidant activities. Nanosci Nanotechnol Int J 2012; 2(4): 30-5.
[17]
Kumar T, Udhayakumar E, Sekar M, Senthil MK, Sundarrajan T. Antidiabetic activity of methanolic extract of Hibiscus cannabinus in streptozotocin induced diabetic rats. Int J Pharma Bio Sci 2011; 2(1): 125-30.
[18]
Van Der Vies J. Two methods for the determination of glycogen in liver. Biochem J 1954; 57(3): 410-6.
[http://dx.doi.org/10.1042/bj0570410] [PMID: 13181850]
[19]
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193(1): 265-75.
[http://dx.doi.org/10.1016/S0021-9258(19)52451-6] [PMID: 14907713]
[20]
Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977; 23(5): 882-4.
[http://dx.doi.org/10.1093/clinchem/23.5.882] [PMID: 192488]
[21]
Patton CJ, Crouch SR. Spectrophotometric and kinetics investigation of the Berthelot reaction for the determination of ammonia. Anal Chem 1977; 49(3): 464-9.
[http://dx.doi.org/10.1021/ac50011a034]
[22]
Bergmeyer HU, Bowers GN Jr. hörder M, Moss DW. Provisional recommendations on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 2. IFCC method for aspartate aminotransferase. Clin Chim Acta 1976; 70(2): F19-29.
[http://dx.doi.org/10.1016/0009-8981(76)90437-X] [PMID: 954207]
[23]
Bergmeyer HU. IFCC methods for the measurement of catalytic concentrations of enzymes: Part 3. IFCC method for alanine aminotransferase (L-alanine: 2-oxoglutarate aminotransferase, EC 2.6. 1.2). Clin Chim Acta 1980; 105(1): 147-54.
[http://dx.doi.org/10.1016/0009-8981(80)90105-9] [PMID: 7449135]
[24]
West E, Simon OR, Morrison EY. Streptozotocin alters pancreatic beta-cell responsiveness to glucose within six hours of injection into rats. West Indian Med J 1996; 45(2): 60-2.
[PMID: 8772396]
[25]
Bhattacharya SK, Satyan KS, Chakrabarti A. Effect of Trasina, an Ayurvedic herbal formulation, on pancreatic islet superoxide dismutase activity in hyperglycaemic rats. Indian J Exp Biol 1997; 35(3): 297-9.
[PMID: 9332177]
[26]
Das AV, Padayatti PS, Paulose CS. Effect of leaf extract of Aegle marmelose (L.) Correa ex Roxb. on histological and ultrastructural changes in tissues of streptozotocin induced diabetic rats. Indian J Exp Biol 1996; 34(4): 341-5.
[PMID: 8698423]
[27]
Degirmenci I, Kalender S, Ustuner MC, et al. The effects of acarbose and Rumex patientia on liver ultrastructure in streptozotocin-induced diabetic (type II) rats. Drugs Exp Clin Res 2002; 28(6): 229-34.
[PMID: 12776576]
[28]
Thorup C, Ollerstam A, Persson AEG, Torffvit O. Increased tubuloglomerular feedback reactivity is associated with increased NO production in the streptozotocin-diabetic rat. J Diabetes Complications 2000; 14(1): 46-52.
[http://dx.doi.org/10.1016/S1056-8727(00)00056-8] [PMID: 10925066]
[29]
Loew D, Kaszkin M. Approaching the problem of bioequivalence of herbal medicinal products. Phytother Res 2002; 16(8): 705-11.
[http://dx.doi.org/10.1002/ptr.1248] [PMID: 12458470]
[30]
Chakravarthy BK, Saroj G, Gambhir SS, Gode KD. Pancreatic beta cell regeneration–a novel antidiabetic mechanism of Pterocarpus marsupium roxb. Indian J Pharmacol 1980; 12(2): 123.
[31]
Pepato MT, Migliorini RH, Goldberg AL, Kettelhut IC. Role of different proteolytic pathways in degradation of muscle protein from streptozotocin-diabetic rats. Am J Physiol 1996; 271(2 Pt 1): E340-7.
[PMID: 8770029]
[32]
Tallroth G, Lindgren M, Stenberg G, Rosén I, Agardh CD. Neurophysiological changes during insulin-induced hypoglycaemia and in the recovery period following glucose infusion in type 1 (insulin-dependent) diabetes mellitus and in normal man. Diabetologia 1990; 33(5): 319-23.
[http://dx.doi.org/10.1007/BF00403327] [PMID: 2198189]
[33]
Bierman EL. George lyman duff memorial lecture. Atherogenesis in diabetes. Arterioscler Thromb 1992; 12(6): 647-56.
[http://dx.doi.org/10.1161/01.ATV.12.6.647] [PMID: 1591228]
[34]
Orchard TJ. Dyslipoproteinemia and diabetes. Endocrinol Metab Clin North Am 1990; 19(2): 361-80.
[http://dx.doi.org/10.1016/S0889-8529(18)30330-X] [PMID: 2192878]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy